CUSIP: 81751A108 | NYSE | Healthcare · Biotechnology | Micro Cap | 51 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13G/ASio Capital Management, LLC | 2,000,000 | 7.9% | New 5%+ stake | Sep 30, 2026 | 1,000,000 sh (Jun 30, 2026) |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 88,888 | $177.8K | 0.0% | Core | Medium | Scottsdale, AZ | 2026-11-03 | |
| 32,203 | $64.4K | 0.0% | Index | Very Low | Boston, MA | 2026-11-06 | |
| 18,800 | $37.6K | 0.0% | ETF | Low | Houston, TX | 2026-10-08 | |
| 5,230 | $10.5K | 0.0% | Core | Medium | New York, NY | 2026-11-04 | |
| 3,682 | $7.4K | 0.0% | Growth | Very High | Hong Kong, South Korea | 2026-10-29 | |
| 28 | $56 | 0.0% | Core | Very Low | Portsmouth, NH | 2026-10-21 | |
| 8 | $16 | 0.0% | Core | Low | Surrey, South Africa | 2026-10-09 | |
| 8 | $16 | 0.0% | Growth | Low | Salt Lake City, UT | 2026-10-21 | |
| 4 | $8 | 0.0% | Core | Medium | London, United Kingdom | 2026-11-06 | |
| 1 | $2 | 0.0% | Index | Low | San Francisco, CA | 2026-10-08 |